These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32310185)

  • 1. Assessment and Management of Urinary Dysfunction in 187 Patients with Parkinson's Disease.
    Jia C; Cui X; Yoshimura N; Mao W; Xu E; Wang Q; Ou T
    J Parkinsons Dis; 2020; 10(3):993-1001. PubMed ID: 32310185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic Parkinson's disease patients at the urologic clinic.
    Ragab MM; Mohammed ES
    Neurourol Urodyn; 2011 Sep; 30(7):1258-61. PubMed ID: 21404318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease.
    Liu Z; Uchiyama T; Sakakibara R; Yamamoto T
    Int Urol Nephrol; 2015 May; 47(5):751-7. PubMed ID: 25792006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders.
    Sakakibara R; Panicker J; Finazzi-Agro E; Iacovelli V; Bruschini H;
    Neurourol Urodyn; 2016 Jun; 35(5):551-63. PubMed ID: 25810035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms.
    Araki I; Kitahara M; Oida T; Kuno S
    J Urol; 2000 Nov; 164(5):1640-3. PubMed ID: 11025724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
    Roth B; Studer UE; Fowler CJ; Kessler TM
    J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary dysfunction in early and untreated Parkinson's disease.
    Uchiyama T; Sakakibara R; Yamamoto T; Ito T; Yamaguchi C; Awa Y; Yanagisawa M; Higuchi Y; Sato Y; Ichikawa T; Yamanishi T; Hattori T; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1382-6. PubMed ID: 21670077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity.
    Kuo HC
    Urology; 2003 Mar; 61(3):550-4. PubMed ID: 12639645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary symptoms and urodynamic findings in Parkinson's disease].
    Barrero R; Mir P; Cayuela A; Campoy P; Pena JM; Alberca R
    Neurologia; 2007 Mar; 22(2):93-8. PubMed ID: 17323234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity.
    Conte A; Giannantoni A; Proietti S; Giovannozzi S; Fabbrini G; Rossi A; Porena M; Berardelli A
    Eur J Neurol; 2012 May; 19(5):725-32. PubMed ID: 22212295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder.
    Giannantoni A; Conte A; Proietti S; Giovannozzi S; Rossi A; Fabbrini G; Porena M; Berardelli A
    J Urol; 2011 Sep; 186(3):960-4. PubMed ID: 21791351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings.
    Nitti VW; Kim Y; Combs AJ
    J Urol; 1997 Feb; 157(2):600-3. PubMed ID: 8996367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Winge K; Werdelin LM; Nielsen KK; Stimpel H
    Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of holmium laser enucleation of the prostate (HoLEP) in men with bladder outlet obstruction (BOO) and non-neurogenic bladder dysfunction.
    Pyun JH; Kang SG; Kang SH; Cheon J; Kim JJ; Lee JG
    Kaohsiung J Med Sci; 2017 Sep; 33(9):458-463. PubMed ID: 28865604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report.
    Al Edwan GM; Mansi HH; Atta ONM; Shaath MM; Al Adwan R; Mahafza W; Afram KM; Ababneh O; Al Adwan D; Muheilan MM
    J Pediatr Surg; 2019 Mar; 54(3):595-599. PubMed ID: 29887168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic findings in women with refractory overactive bladder symptoms.
    Al-Zahrani AA; Gajewski J
    Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic analysis and treatment of male Parkinson's disease patients with voiding dysfunction.
    Xue P; Wang T; Zong H; Zhang Y
    Chin Med J (Engl); 2014; 127(5):878-81. PubMed ID: 24571881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.